Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-02-16

FDA Approved: PHENYTOIN SODIUM — Supplemental Application (Acella Pharmaceuticals, LLC)

View source ↗

Summary

The FDA has approved Acella Pharmaceuticals' supplemental application for phenytoin sodium. This action pertains to their generic anti-seizure medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PHENYTOIN SODIUM (phenytoin sodium)

Snippet

SUPPL AP for PHENYTOIN SODIUM (PHENYTOIN SODIUM)